Shire Remains Undervalued as Takeda Weighs Higher Bid and Allergan Enters the Picture
Shire PLC (SHP LN) has released details of recent negotiations with Takeda Pharmaceutical Co Ltd (4502 JP), detailing three proposed (and rejected)...
315 Views
Will Actinogen Ace Alzheimer's?
Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...
424 Views
Biosimilar Battlefield: An Update
Korea's biosimilar plays, Celltrion Inc (068270 KS) , Celltrion Pharm Inc (068760 KS) , Celltrion Healthcare (091990 KS) , and Samsung Biologics...
592 Views
Insider Trading Alleged as Sanofi Continues Its Shopping Spree
The Securities and Exchange Commission (SEC) believes that insider trading occurred around Sanofi (SAN FP) 's $11.6 billion deal for Bioverativ Inc...
335 Views
Sisram Medical IPO: Israeli Technology, China Story
Sisram Medical is raising up to USD174m in its Hong Kong listing. Sisram Medical is an Israel headquartered meditech company with backing from...
809 Views